|
EP2190863B1
(en)
*
|
2007-07-31 |
2015-09-02 |
Affibody AB |
New albumin binding compositions, methods and uses
|
|
EP2437767B1
(en)
*
|
2009-06-01 |
2015-07-08 |
MedImmune, LLC |
Molecules with extended half-lives and uses thereof
|
|
CA2789738C
(en)
*
|
2010-03-08 |
2021-03-09 |
Ge Healthcare Bio-Sciences Ab |
Immunoglobulin g fc region binding polypeptide
|
|
MX2012012383A
(es)
*
|
2010-04-30 |
2012-11-30 |
Sanwa Kagaku Kenkyusho Co |
Peptido para mejorar la bioestabilidad de una sustancia bioactica y sustancia bioactiva que tiene bioestabilidad mejorada.
|
|
CN103003296A
(zh)
|
2010-07-09 |
2013-03-27 |
阿菲博迪公司 |
多肽
|
|
AU2011286024B2
(en)
*
|
2010-08-02 |
2014-08-07 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
CA2812951A1
(en)
|
2010-09-28 |
2012-04-19 |
Amylin Pharmaceuticals, Llc |
Engineered polypeptides having enhanced duration of action
|
|
PT2621515T
(pt)
*
|
2010-09-28 |
2017-07-12 |
Aegerion Pharmaceuticals Inc |
Polipéptido quimérico de leptina de foca-ser humano com solubilidade aumentada
|
|
PL2643349T3
(pl)
|
2010-11-26 |
2020-03-31 |
Molecular Partners Ag |
Zaprojektowane białka z powtórzeniami wiążące się z albuminą surowicy
|
|
BR112013029892A2
(pt)
*
|
2011-05-21 |
2016-12-20 |
Macrogenics Inc |
polipeptídeo, molécula de ligação a antígeno, diacorpo e uso de uma porção polipeptídica de uma proteína de ligação a soro desimunizada
|
|
JP6006309B2
(ja)
*
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
CN103957926B
(zh)
*
|
2011-07-08 |
2018-07-03 |
安米林药品有限责任公司 |
具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
|
|
EP3511339B1
(en)
|
2012-02-20 |
2025-04-09 |
IPC Research, LLC |
Polypeptides binding to human complement c5
|
|
HK1208155A1
(en)
*
|
2012-03-28 |
2016-02-26 |
Amylin Pharmaceuticals, Llc |
Transmucosal delivery of engineered polypeptides
|
|
JP2015512902A
(ja)
*
|
2012-03-28 |
2015-04-30 |
アフィボディ・アーベー |
経口投与
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
CN104470944B
(zh)
|
2012-05-25 |
2021-09-14 |
詹森生物科技公司 |
非天然共有白蛋白结合结构域
|
|
WO2014048977A1
(en)
*
|
2012-09-25 |
2014-04-03 |
Affibody Ab |
Albumin binding polzpeptide
|
|
JP6440618B2
(ja)
|
2012-10-05 |
2018-12-19 |
アフィボディ・アーベー |
Ｈｅｒ３結合ポリペプチド
|
|
WO2014064238A1
(en)
*
|
2012-10-25 |
2014-05-01 |
Affibody Ab |
Method for the separation of proteins containing an albumin-binding
|
|
CA2889037C
(en)
*
|
2012-10-25 |
2021-06-22 |
Affibody Ab |
Abd binding polypeptide
|
|
WO2014076179A1
(en)
|
2012-11-14 |
2014-05-22 |
Affibody Ab |
New polypeptide
|
|
US9255262B2
(en)
*
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
HK1213194A1
(zh)
|
2013-03-14 |
2016-06-30 |
Daiichi Sankyo Co., Ltd. |
用於新型的结合蛋白质pcsk9
|
|
WO2014140882A2
(en)
*
|
2013-03-14 |
2014-09-18 |
The Governing Council Of The University Of Toronto |
Scaffolded peptidic libraries and methods of making and screening the same
|
|
AU2014230018B2
(en)
|
2013-03-15 |
2018-02-22 |
Affibody Ab |
New polypeptides
|
|
MX2015014438A
(es)
|
2013-04-18 |
2016-05-18 |
Armo Biosciences Inc |
Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
|
|
EP3010527B1
(en)
|
2013-06-17 |
2018-08-08 |
Armo Biosciences, Inc. |
Method for assessing protein identity and stability
|
|
BR112016003142A2
(pt)
|
2013-08-28 |
2017-10-17 |
Swedish Orphan Biovitrum Ab Publ |
ligação de polipeptídeos estáveis ao c5 do complemento humano
|
|
MX367423B
(es)
|
2013-08-28 |
2019-08-21 |
Affibody Ab |
Polipeptidos de union a c5.
|
|
CN105658232A
(zh)
|
2013-08-30 |
2016-06-08 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素-10治疗疾病和病症的方法
|
|
CN120242030A
(zh)
|
2013-11-11 |
2025-07-04 |
阿尔莫生物科技股份有限公司 |
将白细胞介素-10用于治疗疾病和病症的方法
|
|
US10167322B2
(en)
|
2013-12-20 |
2019-01-01 |
Affibody Ab |
Engineered albumin binding polypeptide
|
|
WO2015187295A2
(en)
|
2014-06-02 |
2015-12-10 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
AU2015296640B2
(en)
|
2014-07-30 |
2020-05-21 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
PL3193930T3
(pl)
|
2014-09-17 |
2019-12-31 |
Affibody Ab |
Nowe polipeptydy
|
|
WO2016060996A2
(en)
|
2014-10-14 |
2016-04-21 |
Armo Biosciences, Inc. |
Interleukin-15 compositions and uses thereof
|
|
AU2015336101A1
(en)
|
2014-10-22 |
2017-04-20 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
EP3701969A1
(en)
|
2014-10-31 |
2020-09-02 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
EP3245224B1
(en)
|
2015-01-12 |
2020-07-15 |
Affibody AB |
Il-17a-binding polypeptides
|
|
WO2016126615A1
(en)
|
2015-02-03 |
2016-08-11 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
WO2016179568A1
(en)
*
|
2015-05-06 |
2016-11-10 |
Protomer Technologies, Inc. |
Glucose responsive insulins
|
|
US20160361415A1
(en)
|
2015-05-28 |
2016-12-15 |
Armo Biosciences, Inc. |
Methods of Using Interleukin-10 for Treating Diseases and Disorders
|
|
EA037478B1
(ru)
|
2015-08-04 |
2021-04-01 |
Дьюк Юниверсити |
Генетически кодируемые внутренне неупорядоченные полимеры-"невидимки" для доставки и способы их применения
|
|
KR20180038553A
(ko)
|
2015-08-25 |
2018-04-16 |
아르모 바이오사이언시스 인코포레이티드 |
질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
CN107022031A
(zh)
*
|
2016-01-29 |
2017-08-08 |
中国人民解放军军事医学科学院微生物流行病研究所 |
融合蛋白HSA1-Vβ1及其应用
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
JP2020500150A
(ja)
|
2016-09-23 |
2020-01-09 |
デューク ユニバーシティ |
下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
|
|
CN107952080A
(zh)
*
|
2016-10-14 |
2018-04-24 |
中国科学院过程工程研究所 |
一种肿瘤靶向多肽-药物偶联衍生物、其制备方法及应用
|
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
|
CN111164104A
(zh)
|
2017-08-09 |
2020-05-15 |
麻省理工学院 |
白蛋白结合肽缀合物及其方法
|
|
WO2019071150A1
(en)
*
|
2017-10-06 |
2019-04-11 |
University Of Utah Research Foundation |
FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE
|
|
US20200239575A1
(en)
*
|
2017-10-06 |
2020-07-30 |
University Of Utah Research Foundation |
A fusion protein for targeted therapy of autoimmune disease
|
|
WO2019147954A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
JP7545894B2
(ja)
|
2018-03-13 |
2024-09-05 |
アフィボディ アクティエボラーグ |
新規足場に基づくポリペプチド
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
US11649275B2
(en)
|
2018-08-02 |
2023-05-16 |
Duke University |
Dual agonist fusion proteins
|
|
US12594347B2
(en)
*
|
2018-09-07 |
2026-04-07 |
Duke University |
Nanoparticulate drug delivery systems
|
|
CN113710229B
(zh)
|
2019-02-25 |
2026-01-06 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|
|
CA3138805A1
(en)
|
2019-06-04 |
2020-12-10 |
Johannes Schilling |
Designed ankyrin repeat domain with improved stability
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
EP3785726A1
(en)
|
2019-09-02 |
2021-03-03 |
Biotest AG |
Factor viii protein with increased half-life
|
|
EP4017521A1
(en)
|
2019-09-02 |
2022-06-29 |
Biotest AG |
Factor viii protein with increased half-life
|
|
WO2021089695A1
(en)
|
2019-11-05 |
2021-05-14 |
Affibody Ab |
Polypeptides
|
|
US20230190881A1
(en)
|
2020-02-17 |
2023-06-22 |
Biotest Ag |
Subcutaneous administration of factor viii
|
|
EP3878515A1
(en)
*
|
2020-03-09 |
2021-09-15 |
Hober Biotech AB |
Therapeutic agent targeting her2
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
KR20230123989A
(ko)
|
2020-12-21 |
2023-08-24 |
애피바디 에이비 |
신규 폴리펩티드
|
|
EP4291251B1
(en)
|
2021-02-15 |
2025-02-19 |
Affibody AB |
Her2-binding polypeptide
|
|
AR128475A1
(es)
|
2022-02-08 |
2024-05-15 |
Affibody Ab |
Polipéptidos y proteínas de fusión con afinidad de unión por tslp
|
|
IL317049A
(en)
|
2022-05-18 |
2025-01-01 |
Protomer Tech Inc |
Aromatic boron-containing compounds and related insulin analogs
|
|
TW202416938A
(zh)
|
2022-08-10 |
2024-05-01 |
日商興和股份有限公司 |
親和體微胞(affibody micelle)藥物複合體
|
|
TW202448926A
(zh)
|
2023-02-17 |
2024-12-16 |
比利時商艾伯霖克斯公司 |
結合新生兒fc受體之多肽
|
|
CN121038816A
(zh)
|
2023-05-04 |
2025-11-28 |
阿菲博迪公司 |
新多肽
|
|
WO2025073871A1
(en)
|
2023-10-03 |
2025-04-10 |
Bicycletx Limited |
Bicyclic peptide ligand complexes specific for tfr1
|
|
TW202545983A
(zh)
|
2024-01-25 |
2025-12-01 |
瑞典商艾菲博迪公司 |
新穎多肽
|
|
CN121041473A
(zh)
*
|
2024-05-29 |
2025-12-02 |
烟台蓝纳成生物技术股份有限公司 |
一种双功能性融合蛋白、放射性核素标记物及其应用
|
|
CN118666961B
(zh)
*
|
2024-08-23 |
2024-11-26 |
通化安睿特生物制药股份有限公司 |
人白蛋白特异结合多肽及其应用
|